In AD patients, increased expression and phosphorylation of mTOR have been observed in the hippocampus, together with elevated levels of its downstream targets, such as S6 kinase 1 (S6K1) and regulatory-associated protein of TOR (RAPTOR). The gene discussed is MTOR; the disease is Alzheimer disease.